arrow
R

Ramón Martí

instituto de salud carlos iii
H指数:41
被引数:5,452

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Equilibrative nucleoside transporter 1 deficiency protects against diet-induced MASLD and is stage-associated in human liver disease

equilibrative nucleoside transporter 1 缺乏可抵抗饮食诱导的MASLD,并与人肝病的分期相关

2026-07-210
OAAI
213.2: Plasma dynamics of DAMPs and cf-mtDNA in controlled DCD lung transplantation: Association with primary graft dysfunction.

213.2: DAMPs和cf-mtDNA在受控DCD肺移植中的血浆动力学及其与原发性移植物功能障碍的关联。

2025-12-010
PRE
NK-A 17E-233I: a novel competitive inhibitor of human dihydroorotate dehydrogenase (DHODH) for cancer therapy

NK-A 17E-233I:一种新型竞争性人二氢乳清酸脱氢酶(DHODH)抑制剂,用于癌症治疗

2025-10-190
OAAI
Successful AAV8 gene therapy on hepatic ex situ machine perfusion for mitochondrial neurogastrointestinal encephalomyopathy

成功的AAV8基因治疗肝异位机器灌注治疗线粒体神经胃肠脑肌病

2025-08-060
PREAI
Guanylate Kinase 1 Deficiency: A Novel and Potentially Treatable Mitochondrial DNA Depletion/Deletions Disease
2024-09-041
OA
Clinical and Genetic Analysis of Patients With TK2 Deficiency
2024-04-014
OAAI
Data from the European registry for patients with McArdle disease (EUROMAC): functional status and social participation
2023-07-250
OAAI
RRM1 variants cause a mitochondrial DNA maintenance disorder via impaired de novo nucleotide synthesis
2022-07-017
OAAI
Systematic Collaborative Reanalysis of Genomic Data Improves Diagnostic Yield in Neurologic Rare Diseases
2022-05-0112
OAAI
Data from the European registry for patients with McArdle disease and other muscle glycogenoses (EUROMAC)
2020-11-2429
OAAI
Creation and implementation of a European registry for patients with McArdle disease and other muscle glycogenoses (EUROMAC registry)
2020-10-155
OAAI
Growth Differentiation Factor 15 is a potential biomarker of therapeutic response for TK2 deficient myopathy
2020-06-2226
OAAI